Invention Grant
- Patent Title: IncRNAS for therapy and diagnosis of angiogenesis
-
Application No.: US16248688Application Date: 2019-01-15
-
Publication No.: US11459561B2Publication Date: 2022-10-04
- Inventor: Thomas Thum , Jan Fiedler
- Applicant: Medizinische Hochschule Hannover
- Applicant Address: DE Hannover
- Assignee: Medizinische Hochschule Hannover
- Current Assignee: Medizinische Hochschule Hannover
- Current Assignee Address: DE Hannover
- Agency: Arentfox Schiff LLP
- Priority: EP14165398 20140422
- Main IPC: C12N15/113
- IPC: C12N15/113 ; C12Q1/6883
Abstract:
The present invention relates to a pharmaceutical composition comprising (i) a compound promoting the expression and/or the activity of one or more long non-coding RNAs (lncRNAs) selected from SEQ ID NOs 1 to 22, preferably selected from SEQ ID NOs 1 to 3; and/or (ii) a compound inhibiting the expression and/or the activity of one or more lncRNAs selected from SEQ ID NOs 23 to 42. The present invention also relates to a pharmaceutical composition comprising (i) a compound promoting the expression and/or the activity of one or more lncRNAs selected from SEQ ID NOs 23 to 42; and/or (ii) a compound inhibiting the expression and/or the activity of one or more long non-coding RNAs (lncRNAs) selected from SEQ ID NOs 1 to 22, preferably selected from SEQ ID NOs 1 to 3.
Information query
IPC分类:
